Pulmonary nodules associated with JAK inhibitor therapy in rheumatoid arthritis

Pannell, N.; Joseph, Darren; Ally, Mahmood Moosa Tar Mahomed; Bida, Nndweleni Meshack; Tintinger, Gregory Ronald

dc.contributor.author	Pannell, N.
dc.contributor.author	Joseph, Darren
dc.contributor.author	Ally, Mahmood Moosa Tar Mahomed
dc.contributor.author	Bida, Nndweleni Meshack
dc.contributor.author	Tintinger, Gregory Ronald
dc.date.accessioned	2022-06-23T11:27:58Z
dc.date.available	2022-06-23T11:27:58Z
dc.date.issued	2021
dc.description.abstract	Patients with rheumatoid arthritis (RA) may receive Janus kinase (JAK) inhibitors to achieve optimal control of their disease. We report a case of a patient who received a selective JAK1 inhibitor and subsequently developed multiple pulmonary nodules with cavitation. Biopsies confirmed the presence of cryptococcosis and the patient responded well to anti-fungal therapy.	en_US
dc.description.department	Internal Medicine	en_US
dc.description.librarian	am2022	en_US
dc.description.uri	http://www.ajtccm.org.za/index.php/SARJ	en_US
dc.identifier.citation	Pannell, N., Joseph, D., Ally, M.M.T.M. et al. 2021, 'Pulmonary nodules associated with JAK inhibitor therapy in rheumatoid arthritis', African Journal of Thoracic and Critical Care Medicine, vol. 27, no. 3, pp. 123-125, doi : 10.7196/AJTCCM.2021.v27i3.116 .	en_US
dc.identifier.issn	2617-0205
dc.identifier.other	10.7196/AJTCCM.2021.v27i3.116
dc.identifier.uri	https://repository.up.ac.za/handle/2263/85933
dc.language.iso	en	en_US
dc.publisher	South African Medical Association	en_US
dc.rights	South African Medical Association	en_US
dc.subject	Janus kinase inhibitors	en_US
dc.subject	Opportunistic infections	en_US
dc.subject	Rheumatoid arthritis (RA)	en_US
dc.title	Pulmonary nodules associated with JAK inhibitor therapy in rheumatoid arthritis	en_US
dc.type	Article	en_US